The National Health Service was established in the UK in _____ and based at first on _____.A.1948, Acts of ParliamentB.1958, Acts of ParliamentC.1948, the Bill of RightsD.1958, the Bill of Rights

题目
The National Health Service was established in the UK in _____ and based at first on _____.

A.1948, Acts of Parliament

B.1958, Acts of Parliament

C.1948, the Bill of Rights

D.1958, the Bill of Rights


相似考题

1.Part BDirections:In the following text, some sentences have removed. For Questions 41-45, choose the most suitable one from the list A-G to fit into of the numbered blank there are two extra choices, which do not fit in any of the gaps. Mark your answers on ANSWER SHEET 1. (10 points)Canada’s premiers (the leaders of provincial governments), if they have any breath left after complaining about Ottawa at their late July annual meeting, might spare a moment to do something, together, to reduce health-care costs.They’re all groaning about soaring health budgets, the fastest-growing component of which are pharmaceutical costs.41. ________What to do? Both the Romanow commission and the Kirby committee on health care -- to say nothing of reports from other experts -- recommended the creation of a national drug agency. Instead of each province having its own list of approved drugs, bureaucracy, procedures and limited bargaining power, all would pool resources, work with Ottawa, and create a national institution.42. ________But “national” doesn’t have to mean that. “National” could mean interprovincial -- provinces combining efforts to create one body.Either way, one benefit of a “national” organization would be to negotiate better prices, if possible, with drug manufacturers. Instead of having one province -- or a series of hospitals within a province -- negotiate a price for a given drug on the provincial list, the national agency would negotiate on behalf of all provinces.Rather than, say, Quebec, negotiating on behalf of seven million people, the national agency would negotiate on behalf 31 million people. Basic economics suggests the greater the potential consumers, the higher the likelihood of a better price.43. ________A small step has been taken in the direction of a national agency with the creation of the Canadian Coordinating Office for Health Technology Assessment, funded by Ottawa and the provinces. Under it, a Common Drug Review recommends to provincial lists which new drugs should be included. Predictably, and regrettably, Quebec refused to join.A few premiers are suspicious of any federal-provincial deal-making. They (particularly Quebec and Alberta) just want Ottawa to fork over additional billions with few, if any, strings attached. That’s one reason why the idea of a national list hasn’t gone anywhere while drug costs keep rising fast.44. ________Premiers love to quote Mr. Romanow’s report selectively, especially the parts about more federal money. Perhaps they should read what he had to say about drugs: “A national drug agency would provide governments more influence on pharmaceutical companies in order to constrain the ever-increasing cost of drugs.”45. ________So when the premiers gather in Niagara Falls to assemble their usual complaint list, they should also get cracking about something in their jurisdiction that would help their budgets and patients.41.___________________[A] Quebec’s resistance to a national agency is provincialist ideology. One of the first advocates for a national list was a researcher at Laval University. Quebec’s Drug Insurance Fund has seen its costs skyrocket with annual increases from 14.3 per cent to 26.8 per cent![B] Or they could read Mr. Kirby’s report: “the substantial buying power of such an agency would strengthen the public prescription-drug insurance plans to negotiate the lowest possible purchase prices from drug companies.”[C] What does “national” mean? Roy Romanow and Senator Michael Kirby recommended a federal-provincial body much like the recently created National Health Council.[D] The problem is simple and stark: health-care costs have been, are, and will continue to increase faster than government revenues.[E] According to the Canadian Institute for Health Information, prescription drug costs have risen since 1997 at twice the rate of overall health-care spending. Part of the increase comes from drugs being used to replace other kinds of treatments. Part of it arises from new drugs costing more than older kinds. Part of it is higher prices.[F] So, if the provinces want to run the health-care show, they should prove they can run it, starting with an interprovincial health list that would end duplication, save administrative costs, prevent one province from being played off against another, and bargain for better drug prices.[G] Of course the pharmaceutical companies will scream. They like divided buyers; they can lobby better that way. They can use the threat of removing jobs from one province to another. They can hope that, if one province includes a drug on its list, the pressure will cause others to include it on theirs. They wouldn’t like a national agency, but self-interest would lead them to deal with it.

2.________________[A] Quebec’s resistance to a national agency is provincialist ideology. One of the first advocates for a national list was a researcher at Laval University. Quebec’s Drug Insurance Fund has seen its costs skyrocket with annual increases from 14.3 per cent to 26.8 per cent![B] Or they could read Mr. Kirby’s report: “the substantial buying power of such an agency would strengthen the public prescription-drug insurance plans to negotiate the lowest possible purchase prices from drug companies.”[C] What does “national” mean? Roy Romanow and Senator Michael Kirby recommended a federal-provincial body much like the recently created National Health Council.[D] The problem is simple and stark: health-care costs have been, are, and will continue to increase faster than government revenues.[E] According to the Canadian Institute for Health Information, prescription drug costs have risen since 1997 at twice the rate of overall health-care spending. Part of the increase comes from drugs being used to replace other kinds of treatments. Part of it arises from new drugs costing more than older kinds. Part of it is higher prices.[F] So, if the provinces want to run the health-care show, they should prove they can run it, starting with an interprovincial health list that would end duplication, save administrative costs, prevent one province from being played off against another, and bargain for better drug prices.[G] Of course the pharmaceutical companies will scream. They like divided buyers; they can lobby better that way. They can use the threat of removing jobs from one province to another. They can hope that, if one province includes a drug on its list, the pressure will cause others to include it on theirs. They wouldn’t like a national agency, but self-interest would lead them to deal with it.

3.__________[A] Quebec’s resistance to a national agency is provincialist ideology. One of the first advocates for a national list was a researcher at Laval University. Quebec’s Drug Insurance Fund has seen its costs skyrocket with annual increases from 14.3 per cent to 26.8 per cent![B] Or they could read Mr. Kirby’s report: “the substantial buying power of such an agency would strengthen the public prescription-drug insurance plans to negotiate the lowest possible purchase prices from drug companies.”[C] What does “national” mean? Roy Romanow and Senator Michael Kirby recommended a federal-provincial body much like the recently created National Health Council.[D] The problem is simple and stark: health-care costs have been, are, and will continue to increase faster than government revenues.[E] According to the Canadian Institute for Health Information, prescription drug costs have risen since 1997 at twice the rate of overall health-care spending. Part of the increase comes from drugs being used to replace other kinds of treatments. Part of it arises from new drugs costing more than older kinds. Part of it is higher prices.[F] So, if the provinces want to run the health-care show, they should prove they can run it, starting with an interprovincial health list that would end duplication, save administrative costs, prevent one province from being played off against another, and bargain for better drug prices.[G] Of course the pharmaceutical companies will scream. They like divided buyers; they can lobby better that way. They can use the threat of removing jobs from one province to another. They can hope that, if one province includes a drug on its list, the pressure will cause others to include it on theirs. They wouldn’t like a national agency, but self-interest would lead them to deal with it.

4._______________[A] Quebec’s resistance to a national agency is provincialist ideology. One of the first advocates for a national list was a researcher at Laval University. Quebec’s Drug Insurance Fund has seen its costs skyrocket with annual increases from 14.3 per cent to 26.8 per cent![B] Or they could read Mr. Kirby’s report: “the substantial buying power of such an agency would strengthen the public prescription-drug insurance plans to negotiate the lowest possible purchase prices from drug companies.”[C] What does “national” mean? Roy Romanow and Senator Michael Kirby recommended a federal-provincial body much like the recently created National Health Council.[D] The problem is simple and stark: health-care costs have been, are, and will continue to increase faster than government revenues.[E] According to the Canadian Institute for Health Information, prescription drug costs have risen since 1997 at twice the rate of overall health-care spending. Part of the increase comes from drugs being used to replace other kinds of treatments. Part of it arises from new drugs costing more than older kinds. Part of it is higher prices.[F] So, if the provinces want to run the health-care show, they should prove they can run it, starting with an interprovincial health list that would end duplication, save administrative costs, prevent one province from being played off against another, and bargain for better drug prices.[G] Of course the pharmaceutical companies will scream. They like divided buyers; they can lobby better that way. They can use the threat of removing jobs from one province to another. They can hope that, if one province includes a drug on its list, the pressure will cause others to include it on theirs. They wouldn’t like a national agency, but self-interest would lead them to deal with it.

更多“The National Health Service was established in the UK in _____ and based at first on _____. ”相关问题
  • 第1题:

    ●Thebasic concept of a data (72) is the difference between data and information.

    (72) A.warehouse

    B.storage

    C.base

    D.service


    正确答案:A
    【解析】数据仓库的基本概念就是数据和信息的不同。

  • 第2题:

    线路发生两相短路时,短路点处正序电压与负序电压的关系为()。

    A.UK1>UK2

    B.UK1=UK2

    C.UK1<UK2


    参考答案:B

  • 第3题:

    Traditional IP packet forwarding analyzes the(请作答此空)IP address contained in the network layer header of each packet as the packet travels from its source to its final destination.A router analyzes the destination IP address independently at each hop in the network.Dynamic( )protocols or static configuration builds the database needed to analyze the destination IP address(the routing table).The process of implementing traditional IP routing also is called hop-by-hop destination-based( )routing.Although successful,and obviously widely deployed,certain restrictions,which have been realized for some time,exist for this method of packet forwarding that diminish is( ).New techniques are therefore required to address and expand the functionality of an IP-based network infrastructure.This first chapter concentrates on identifying these restrictions and presents a new archiecture,known as multiprotocol( )switching,that provides solutions some of these restrictions.

    A.datagram
    B.destination
    C.connection
    D.service

    答案:B
    解析:
    传统的IP数据包转发分析目的IP地址,该地址包含在每个从源到最终目的地的网络层数据包的头部。一个路由器的分析目的IP地址,该地址独立在网络中的每跳。动态路由协议或静态配置构建数据库,该数据数据库需要分析目的IP地址(路由表)。实施传统的IP路由的过程也叫作基于目的地的逐条单播路由。虽然成功而且明显得广泛部署,并实现了一段时间,但是必然有某些限制,这种数据包转发方法的存在是减少了灵活性。新技术是因此需要地址和扩展一个基于ip的网络基础设施的功能。第一章集中在识别一种新的架构的限制条件和反馈,该架构众所周知是多协议标签交换,它为其中的一些限制条件提供解决方案。

  • 第4题:

    HSE是指( )。

    A、harmony,safety,education的缩写

    B、harm,service,energy的缩写

    C、health,safety,environment的缩写

    D、health,safety,energy的缩写


    答案:C

  • 第5题:

    The basic concept of a data(72)is the difference between data and information.

    A.warehouse

    B.storage

    C.base

    D.service


    正确答案:A
    解析:数据仓库的基本概念就是数据和信息的不同。

  • 第6题:

    LA1A3330 两相故障时,故障点的正序电压UK1与负序电压UK2的关系为( )。

    (A)UK1 >UK2(B)UK1 =UK2(C)UK1 <UK2(D)UK1 =UK2=0

    答案:B
    解析: